About TreeFRog Therapeutics

We bring together biophysicists, stem cell biologists & bioproduction engineers around the motto
"Cell Therapy for All"

THE VISION

TreeFrog Therapeutics was created to provide access to safe, efficient and affordable cell therapies for millions of patients.

TreeFrog TODAY

TreeFrog Therapeutics is advancing a pipeline of cell therapies with the aim of a first-in-human trial in 2024.

TreeFrog Today

Hyper-growth since incorporation in 2018

0 +
team
$ 0 M
raised since 2018
0
patent families
0
Advanced cell therapies
EXecutive team

Frédéric Desdouits, PhD

Chief Executive Officer
Kévin Alessandri TreeFrog Therapeutics

Kévin Alessandri, PhD

Co-Founder, Chief Technology Officer

Maxime Feyeux, PhD

Co-Founder, Chief Scientific Officer
Marie Catoire TreeFrog

Marie Catoire, MBA

Secretary General
Pascale Berthet TreeFrog

Pascale Berthet, MSc

Chief Business Development officer
myriam m

Myriam Makhloufi, MSc

BUSINESS STRATEGY OFFICER

Michael Lanero Fidalgo, MBA

Chief Operating Officer

Fabien Moncaubeig, MSc

Chief Development Officer
Gabriel Chaigneau TreeFrog

Gabriel Chaigneau, MSc

Chief Finance officer
Pierre-Emmanuel Gaultier TreeFrog

Pierre-E Gaultier, MSc

Chief MARCOM Officer
Board members
elsy boglioli

Elsy Boglioli

Chair, INDEPENDENT board MEMBER

Frédéric Desdouits, PhD

Chief Executive Officer
Kévin Alessandri TreeFrog Therapeutics

Kévin Alessandri, PhD

Co-Founder, Chief Technology Officer

Jean-Luc Treillou, PharmD

Co-founder

Melissa Carpenter, PhD

independEnt board MEMBER
Board-Laurent-Higueret

Laurent Higueret

BPI Large Venture

Pete Zippelius

Leonard Green & Partners

Guilhem de Vregille

Xange

Marine Choplain

ObservER, Bpifrance
bryan campbell

Bryan Campbell

Observer, BRISTOL-MYERS SQUIBB
Board

Camille Le Roux Larsabal

Observer, AQUITI Gestion

Maxime Feyeux, PhD

Observer, Co-Founder and CSO
SCIENTIFIC ADVISORY BOARD
Prof Peter Andrews

Prof. Peter Andrews

Emeritus Professor, University of Sheffield, UK
Prof L Mahadevan

Prof. L. Mahadevan

Professor of Physics, de Valpine Professor of Applied Mathematics, Professor of Organismic and Evolutionary Biology, Harvard University, USA
Marta Shahbazi

Marta Shahbazi, PhD

Group Leader, MRC Laboratory of Molecular Biology (LMB) Cambridge, UK
Justin Eyquem

Justin Eyquem, PhD

Assistant Professor, University of California San Francisco, Co-founder of Mnemo Therapeutics, USA
Shin Kawamata

Shin Kawamata, MD, PhD

Director, Research and Development Center for Cell Therapy, FBRI Kobe, Japan
Pierre Nassoy

Pierre Nassoy, PhD

Research Director, CNRS,
co-inventor of C-SteM technology, Bordeaux, France
They trust us

Our partners

eic scaling up logo
French tech 120
Scientific COLLABORATions
INvestors
Public funding
EARLY SUPPORT
European Commission

TreeFrog Therapeutics is receiving funding from the European Union’s Horizon 2020 research and innovation program through the SME Instrument Phase 2 under grant agreement n° SME 881113.

Logo Feder
Nouvelle-Aquitaine

La Région et l’Union européenne soutiennent le projet CHAMBERLAN dans le cadre du « Programme Opérationnel FEDER/FSE Aquitaine 2014-2020 » en conformité avec la règlementation européenne en matière de Fonds européens structurels et d’investissement (FESI).